Post job

NOVEC's revenue is $9.3 million.

What is NOVEC's revenue?

NOVEC's annual revenue is $9.3M. Zippia's data science team found the following key financial metrics about NOVEC after extensive research and analysis.
  • NOVEC has 350 employees, and the revenue per employee ratio is $26,571.
  • NOVEC peak revenue was $9.3M in 2024.

On this page

Peak revenue
$9.3M (2024)
Company peak revenue
Revenue / employee
$26,571
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$9.3M (2024)
Company peak revenue
Revenue / employee
$26,571
Company revenue / employee

NOVEC competitors

NOVEC's top competitor, Potomac Electric Power Company, earned an annual revenue of $23.0B.

NOVEC's smallest competitor is Clayton County Water Authority with revenue of $1.0M last year.

NOVEC revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of NOVEC, including salaries, political affiliations, employee data, and more, in order to inform job seekers about NOVEC. The employee data is based on information from people who have self-reported their past or current employments at NOVEC. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by NOVEC. The data presented on this page does not represent the view of NOVEC and its employees or that of Zippia.

NOVEC may also be known as or be related to NORTHERN VIRGINIA ELECTRIC CO-OP, NOVEC, Northern Virginia Electric Cooperative and Novec.